サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1703034

がん免疫療法創薬アウトソーシングの世界市場レポート 2025年

Cancer Immunotherapy Drug Discovery Outsourcing Global Market Report 2025

出版日
ページ情報
英文 200 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.96円
がん免疫療法創薬アウトソーシングの世界市場レポート 2025年
出版日: 2025年04月01日
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

がん免疫療法創薬アウトソーシングの市場規模は今後数年で急成長が見込まれます。2029年にはCAGR11.3％で25億7,000万米ドルに成長します。予測期間における成長の背景には、個別化医療の重要性の高まり、診断検査の増加、個別化がん治療への注目の高まり、医療支出の増加、がん罹患率と認知度の向上があります。予測期間における主要動向としては、診断技術の進歩、次世代シーケンス（NGS）、人工知能（AI）の統合、リキッドバイオプシー技術、ポイントオブケア型コンパニオン診断機器の開発、革新的な検査技術などが挙げられます。

研究開発（R&D）に関連する費用の高騰は、がん免疫療法創薬アウトソーシング市場の拡大を促進すると予測されています。多額の研究開発費は、専門的な知識、高価な機器、技術革新に伴う固有のリスクの必要性から生じています。創薬活動のアウトソーシングは、開発業務受託機関（CRO）が提供するスケールメリットを活用することで、小規模なバイオテクノロジー企業や新興企業が研究開発予算を最適化し、リソースをより効率的に配分することを可能にし、費用対効果を高めています。例えば、2023年6月に欧州製薬団体連合会（EFPIA）が報告したところによると、2022年の欧州の医薬品研究開発費総額は495億米ドル（445億ユーロ）に達し、2021年の465億米ドル（425億3,300万ユーロ）から約6.45％増加しました。その結果、自社研究開発に関連する法外なコストががん免疫療法創薬アウトソーシング市場の成長に拍車をかけています。

がん免疫療法創薬アウトソーシング市場の主要参入企業は、抗がん剤生産を強化し、競合優位性を獲得するために、戦略的パートナーシップのアプローチを採用しています。戦略的パートナーシップは通常、2つ以上の組織が協力関係を結び、共通の目標や目的を達成するためにリソースや専門知識、努力を出し合うことを意味します。例えば、2022年2月、日本の製薬会社である小野薬品工業株式会社と米国のバイオ医薬品会社であるブリストル・マイヤーズスクイブ社は、日本の研究機関である株式会社プライムメディカルリサーチラボと、オプジーボ（ニボルマブ）と化学療法を併用した胃がん患者に焦点を当てた共同臨床研究プロジェクトに関する業務委託契約を締結しました。この共同研究は、PRiME-RのCyberOncologyデータ入力支援システムを用いた大規模な多施設共同研究であり、日常的ながん臨床における実臨床データの標準化、構造化、管理、統合を促進するものです。CyberOncologyを活用した臨床研究では、未治療の進行・再発胃がんに対するオプジーボと化学療法の併用効果を評価します。全国約30の医療機関が参加し、データ入力の効率化、データの正確性の向上、分析の迅速化を目指しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場-金利、インフレ、地政学、新型コロナウイルス感染症、景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界のがん免疫療法創薬アウトソーシング PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
  • 最終用途産業の分析
  • 世界のがん免疫療法創薬アウトソーシング市場：成長率分析
  • 世界のがん免疫療法創薬アウトソーシング市場の実績：規模と成長、2019～2024年
  • 世界のがん免疫療法創薬アウトソーシング市場の予測：規模と成長、2024～2029年、2034年
  • 世界のがん免疫療法創薬アウトソーシング総アドレス可能市場（TAM）

第6章 市場セグメンテーション

  • 世界のがん免疫療法創薬アウトソーシング市場、薬剤タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • モノクローナル抗体
  • 免疫調節薬
  • 腫瘍溶解性ウイルス療法とがんワクチン
  • その他の薬剤タイプ
  • 世界のがん免疫療法創薬アウトソーシング市場：サービスタイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • 対象の識別と検証
  • 鉛のスクリーニングと特性評価
  • 細胞ベースアッセイ
  • 世界のがん免疫療法創薬アウトソーシング市場、治療領域別、実績と予測、2019～2024年、2024～2029年、2034年
  • 肺がん
  • 乳がん
  • 黒色腫
  • その他の治療領域
  • 世界のがん免疫療法創薬アウトソーシング市場、モノクローナル抗体のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • チェックポイント阻害剤
  • 治療用モノクローナル抗体
  • 二重特異性抗体
  • 抗体薬剤複合体（ADC）
  • 世界のがん免疫療法創薬アウトソーシング市場、免疫調節剤のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • サイトカイン
  • 免疫チェックポイント調節因子
  • Toll様受容体作動薬
  • 免疫アジュバント
  • 世界のがん免疫療法創薬アウトソーシング市場、腫瘍溶解性ウイルス療法とがんワクチンタイプ別サブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • 腫瘍溶解性ウイルスベースの治療法
  • がんワクチン
  • 免疫療法のためのウイルスベクタ
  • 世界のがん免疫療法創薬アウトソーシング市場、その他薬剤タイプのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • 養子細胞療法
  • 免疫細胞調節剤
  • 小分子免疫調節剤
  • 遺伝子編集と免疫療法

第7章 地域別・国別分析

  • 世界のがん免疫療法創薬アウトソーシング市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
  • 世界のがん免疫療法創薬アウトソーシング市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • がん免疫療法創薬アウトソーシング市場：競合情勢
  • がん免疫療法創薬アウトソーシング市場：企業プロファイル
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Laboratory Corporation of America Holdings（LabCorp）
    • Eurofins Scientific SE
    • WuXi AppTec Co Ltd.

第31章 その他の大手企業と革新的企業

  • Charles River Laboratories International Inc.
  • PerkinElmer Inc
  • Bio-Rad Laboratories Inc
  • QIAGEN N.V.
  • Evotec SE
  • Shanghai ChemPartner Co. Ltd.
  • Aragen Life Sciences Limited
  • GenScript BIoTech Corporation
  • BGI Genomics Co. Ltd.
  • NeoGenomics Laboratories Inc
  • ARUP Laboratories
  • Syngene International Limited
  • BioDuro-Sundia
  • Ambry Genetics Corporation
  • Selvita

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、戦略

  • がん免疫療法創薬アウトソーシング市場、2029年：新たな機会を提供する国
  • がん免疫療法創薬アウトソーシング市場、2029年：新たな機会を提供するセグメント
  • がん免疫療法創薬アウトソーシング市場、2029年：成長戦略
    • 市場動向による戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r29690

Cancer immunotherapy drug discovery outsourcing is a specialized service model within the pharmaceutical and biotech sectors. It involves entrusting aspects of cancer immunotherapy drug development to external service providers, typically contract research organizations (CROs) or contract development and manufacturing organizations (CDMOs). This approach accelerates innovation by leveraging external expertise and resources, allowing pharmaceutical companies to concentrate on their core activities.

The primary drug types involved in cancer immunotherapy drug discovery outsourcing include monoclonal antibodies, immunomodulators, oncolytic viral therapies, cancer vaccines, and others. Monoclonal antibodies are laboratory-made molecules that mimic the immune system's ability to target specific proteins on cancer cells, aiding in fighting off harmful pathogens. The services provided encompass target identification and validation, lead screening and characterization, and cell-based assays utilized in therapeutic areas such as lung cancer, breast cancer, melanoma, and others.

The cancer immunotherapy drug discovery outsourcing market research report is one of a series of new reports from The Business Research Company that provides cancer immunotherapy drug discovery outsourcing market statistics, including cancer immunotherapy drug discovery outsourcing industry global market size, regional shares, competitors with a cancer immunotherapy drug discovery outsourcing market share, detailed cancer immunotherapy drug discovery outsourcing market segments, market trends and opportunities, and any further data you may need to thrive in the cancer immunotherapy drug discovery outsourcing industry. This cancer immunotherapy drug discovery outsourcing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cancer immunotherapy drug discovery outsourcing market size has grown rapidly in recent years. It will grow from $1.5 billion in 2024 to $1.68 billion in 2025 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to increasing cases of adverse drug reactions, increasing demand for comprehensive genomic testing, increasing global incidence of cancer, a growing need for targeted therapy, and a growing number of clinical trials.

The cancer immunotherapy drug discovery outsourcing market size is expected to see rapid growth in the next few years. It will grow to $2.57 billion in 2029 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to the rising importance of personalized medicine, increasing diagnostic tests, increasing focus on personalized cancer therapy, increasing healthcare expenditure, and increasing cancer incidence and awareness. Major trends in the forecast period include advancements in diagnostic technologies, next-generation sequencing (NGS), integration of artificial intelligence (AI), liquid biopsy technologies, the development of point-of-care companion diagnostic devices, and innovative testing technologies.

The escalating expenses associated with research and development (R&D) are projected to drive the expansion of the cancer immunotherapy drug discovery outsourcing market. The substantial R&D costs stem from the necessity of specialized expertise, costly equipment, and the inherent risks linked with innovation. The outsourcing of drug discovery activities taps into the economies of scale provided by contract research organizations (CROs), enabling smaller biotech firms and startups to optimize their R&D budgets and allocate resources more efficiently, thereby enhancing cost-effectiveness. For instance, in June 2023, as reported by the European Federation of Pharmaceutical Industries and Associations (EFPIA), the total pharmaceutical R&D expenditure in Europe reached $49,500 million (€44,500 million) in 2022, marking a rise of around 6.45% from $46,500 million (€42,533 million) in 2021. Consequently, the exorbitant costs associated with in-house research and development are fueling the growth of the cancer immunotherapy drug discovery outsourcing market.

Key players in the cancer immunotherapy drug discovery outsourcing market are embracing a strategic partnership approach to bolster cancer drug production and gain competitive advantages. Strategic partnerships typically involve collaborative relationships among two or more organizations, pooling their resources, expertise, and efforts to achieve common goals or objectives. For instance, in February 2022, Ono Pharmaceutical Co., Ltd., a Japan-based pharmaceutical company, and Bristol-Myers Squibb, a US-based biopharmaceutical company, forged an outsourcing agreement with Prime Research Institute for Medical Research, Inc., a Japan-based research institute, for a joint clinical research project focused on gastric cancer patients treated with Opdivo (nivolumab) in combination with chemotherapy. This collaborative initiative, sponsored by the industry, encompasses a large-scale, multi-institutional study employing PRiME-R's CyberOncology data input support system, facilitating the standardization, structuring, management, and integration of real-world data in routine cancer clinical practice. The clinical research, utilizing CyberOncology, assesses the effectiveness of Opdivo combined with chemotherapy for untreated advanced or recurrent gastric cancer. Involving approximately 30 medical institutions nationwide, the study aims to streamline data input, improve data accuracy, and expedite analysis.

In February 2022, Ono Pharmaceutical Co. Ltd., a Japan-based pharmaceutical company, entered into a collaboration with Bristol Myers Squibb K.K., a US-based multinational biopharmaceutical company. The partnership aims to conduct a large-scale, multi-institutional clinical research study to assess the efficacy and safety of Opdivo (nivolumab) in combination with chemotherapy for patients with advanced or recurrent gastric cancer. This initiative makes use of PRIMER's CyberOncology system, which standardizes and integrates real-world data from clinical practice, enhancing the accuracy and efficiency of the research process.

Major companies operating in the cancer immunotherapy drug discovery outsourcing market are Thermo Fisher Scientific Inc., Danaher Corporation, Laboratory Corporation of America Holdings (LabCorp), Eurofins Scientific SE, WuXi AppTec Co Ltd., Charles River Laboratories International Inc., PerkinElmer Inc, Bio-Rad Laboratories Inc, QIAGEN N.V., Evotec SE, Shanghai ChemPartner Co. Ltd., Aragen Life Sciences Limited, GenScript Biotech Corporation, BGI Genomics Co. Ltd., NeoGenomics Laboratories Inc, ARUP Laboratories, Syngene International Limited, BioDuro-Sundia, Ambry Genetics Corporation, Selvita, Crown Bioscience International, CENTOGENE N.V., Jubilant Biosys, Oncodesign Services, Icagen Inc., Reaction Biology Corporation, ChemBridge Corporation

North America was the largest region in the cancer immunotherapy drug discovery outsourcing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer immunotherapy drug discovery outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cancer immunotherapy drug discovery outsourcing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cancer immunotherapy drug discovery outsourcing market includes revenues earned by entities by providing services such as preclinical testing, clinical trial support, and biomarker discovery. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cancer Immunotherapy Drug Discovery Outsourcing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cancer immunotherapy drug discovery outsourcing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cancer immunotherapy drug discovery outsourcing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cancer immunotherapy drug discovery outsourcing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Drug Type: Monoclonal Antibodies; Immunomodulators; Oncolytic Viral Therapies And Cancer Vaccines; Other Drug Types
  • 2) By Service Type: Target Identification And Validation; Lead Screening And Characterization; Cell-Based Assays
  • 3) By Therapeutic Area: Lung Cancer; Breast Cancer; Melanoma; Other Therapeutic Areas
  • Subsegments:
  • 1) By Monoclonal Antibodies: Checkpoint Inhibitors; Therapeutic Monoclonal Antibodies; Bispecific Antibodies; Antibody-Drug Conjugates (ADCs)
  • 2) By Immunomodulators: Cytokines; Immune Checkpoint Modulators; Toll-Like Receptor Agonists; Immune Adjuvants
  • 3) By Oncolytic Viral Therapies And Cancer Vaccines: Oncolytic Virus-Based Therapies; Cancer Vaccines; Viral Vectors For Immunotherapy
  • 4) By Other Drug Types: Adoptive Cell Therapy; Immune Cell Modulators; Small Molecule Immune Modulators; Gene Editing And Immunotherapy
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Danaher Corporation; Laboratory Corporation of America Holdings (LabCorp); Eurofins Scientific SE; WuXi AppTec Co Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cancer Immunotherapy Drug Discovery Outsourcing Market Characteristics

3. Cancer Immunotherapy Drug Discovery Outsourcing Market Trends And Strategies

4. Cancer Immunotherapy Drug Discovery Outsourcing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Cancer Immunotherapy Drug Discovery Outsourcing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Cancer Immunotherapy Drug Discovery Outsourcing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Growth Rate Analysis
  • 5.4. Global Cancer Immunotherapy Drug Discovery Outsourcing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Cancer Immunotherapy Drug Discovery Outsourcing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Cancer Immunotherapy Drug Discovery Outsourcing Total Addressable Market (TAM)

6. Cancer Immunotherapy Drug Discovery Outsourcing Market Segmentation

  • 6.1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Monoclonal Antibodies
  • Immunomodulators
  • Oncolytic Viral Therapies And Cancer Vaccines
  • Other Drug Types
  • 6.2. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Target Identification And Validation
  • Lead Screening And Characterization
  • Cell-Based Assays
  • 6.3. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Lung Cancer
  • Breast Cancer
  • Melanoma
  • Other Therapeutic Areas
  • 6.4. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Checkpoint Inhibitors
  • Therapeutic Monoclonal Antibodies
  • Bispecific Antibodies
  • Antibody-Drug Conjugates (ADCs)
  • 6.5. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Sub-Segmentation Of Immunomodulators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cytokines
  • Immune Checkpoint Modulators
  • Toll-Like Receptor Agonists
  • Immune Adjuvants
  • 6.6. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Sub-Segmentation Of Oncolytic Viral Therapies And Cancer Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oncolytic Virus-Based Therapies
  • Cancer Vaccines
  • Viral Vectors For Immunotherapy
  • 6.7. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Sub-Segmentation Of Other Drug Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Adoptive Cell Therapy
  • Immune Cell Modulators
  • Small Molecule Immune Modulators
  • Gene Editing And Immunotherapy

7. Cancer Immunotherapy Drug Discovery Outsourcing Market Regional And Country Analysis

  • 7.1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market

  • 8.1. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cancer Immunotherapy Drug Discovery Outsourcing Market

  • 9.1. China Cancer Immunotherapy Drug Discovery Outsourcing Market Overview
  • 9.2. China Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cancer Immunotherapy Drug Discovery Outsourcing Market

  • 10.1. India Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cancer Immunotherapy Drug Discovery Outsourcing Market

  • 11.1. Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Overview
  • 11.2. Japan Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cancer Immunotherapy Drug Discovery Outsourcing Market

  • 12.1. Australia Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cancer Immunotherapy Drug Discovery Outsourcing Market

  • 13.1. Indonesia Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market

  • 14.1. South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market Overview
  • 14.2. South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cancer Immunotherapy Drug Discovery Outsourcing Market

  • 15.1. Western Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Overview
  • 15.2. Western Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cancer Immunotherapy Drug Discovery Outsourcing Market

  • 16.1. UK Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cancer Immunotherapy Drug Discovery Outsourcing Market

  • 17.1. Germany Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cancer Immunotherapy Drug Discovery Outsourcing Market

  • 18.1. France Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cancer Immunotherapy Drug Discovery Outsourcing Market

  • 19.1. Italy Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cancer Immunotherapy Drug Discovery Outsourcing Market

  • 20.1. Spain Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cancer Immunotherapy Drug Discovery Outsourcing Market

  • 21.1. Eastern Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Overview
  • 21.2. Eastern Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cancer Immunotherapy Drug Discovery Outsourcing Market

  • 22.1. Russia Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cancer Immunotherapy Drug Discovery Outsourcing Market

  • 23.1. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Overview
  • 23.2. North America Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cancer Immunotherapy Drug Discovery Outsourcing Market

  • 24.1. USA Cancer Immunotherapy Drug Discovery Outsourcing Market Overview
  • 24.2. USA Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cancer Immunotherapy Drug Discovery Outsourcing Market

  • 25.1. Canada Cancer Immunotherapy Drug Discovery Outsourcing Market Overview
  • 25.2. Canada Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cancer Immunotherapy Drug Discovery Outsourcing Market

  • 26.1. South America Cancer Immunotherapy Drug Discovery Outsourcing Market Overview
  • 26.2. South America Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market

  • 27.1. Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market

  • 28.1. Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market Overview
  • 28.2. Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cancer Immunotherapy Drug Discovery Outsourcing Market

  • 29.1. Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Overview
  • 29.2. Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cancer Immunotherapy Drug Discovery Outsourcing Market Competitive Landscape And Company Profiles

  • 30.1. Cancer Immunotherapy Drug Discovery Outsourcing Market Competitive Landscape
  • 30.2. Cancer Immunotherapy Drug Discovery Outsourcing Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Laboratory Corporation of America Holdings (LabCorp) Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. WuXi AppTec Co Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Cancer Immunotherapy Drug Discovery Outsourcing Market Other Major And Innovative Companies

  • 31.1. Charles River Laboratories International Inc.
  • 31.2. PerkinElmer Inc
  • 31.3. Bio-Rad Laboratories Inc
  • 31.4. QIAGEN N.V.
  • 31.5. Evotec SE
  • 31.6. Shanghai ChemPartner Co. Ltd.
  • 31.7. Aragen Life Sciences Limited
  • 31.8. GenScript Biotech Corporation
  • 31.9. BGI Genomics Co. Ltd.
  • 31.10. NeoGenomics Laboratories Inc
  • 31.11. ARUP Laboratories
  • 31.12. Syngene International Limited
  • 31.13. BioDuro-Sundia
  • 31.14. Ambry Genetics Corporation
  • 31.15. Selvita

32. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cancer Immunotherapy Drug Discovery Outsourcing Market

34. Recent Developments In The Cancer Immunotherapy Drug Discovery Outsourcing Market

35. Cancer Immunotherapy Drug Discovery Outsourcing Market High Potential Countries, Segments and Strategies

  • 35.1 Cancer Immunotherapy Drug Discovery Outsourcing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Cancer Immunotherapy Drug Discovery Outsourcing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Cancer Immunotherapy Drug Discovery Outsourcing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer